Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section
- PMID:7235275
- DOI: 10.1097/00000542-198106000-00006
Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section
Abstract
This study was undertaken to investigate the effect of pregnancy on the disposition of thiopental and to determine the major factors which influence the placental transfer of the drug to the fetus. Maternal venous (MV) and umbilical venous (UV) and arterial (UA) blood samples were collected at delivery from 11 pregnant women at term who received thiopental for induction of anesthesia for elective cesarian section. A detailed study of the pharmacokinetics of thiopental was carried out in 7 of these subjects and blood samples were collected for 80 to 100 hours following thiopental administration. A transient rise in thiopental plasma concentration was observed at delivery. Mean values of pharmacokinetic parameters (plus or minus SD) were: initial distribution volume (V1) 17.31 (plus or minus 8.5), apparent volume of distribution (Vdbeta) 564 1 (plus or minus 343), volume of distribution at steady state (Vss) 2881 (plus or minus 180), systemic plasma clearance (Clp) 0.286 l/min (plus or minus 0.156), rate of change of volume of distribution at zero time (RVd0) 1.03 l/min (plus or minus 0.36) and elimination half-life (t1/2) 26.1 h (plus or minus 12.6). Comparison of these data with our previously reported data in nonpregnant surgical patients shows that Vdbeta, Vss, T1/2 are significantly greater at cesarian section (P less than 0.05) and that systemic plasma clearance shows a similar trend. UA and UV values at delivery were similar within individuals. There was no correlation between the ratio UV/MV at delivery and the dosing-delivery interval (delta t), or between UV and the administered dose or delta t. There were good correlations between UV (corrected for dose) and the reciprocals of V1, Vdbeta, Vss, and plasma clearance of thiopental. This demonstrates that differences in maternal distribution and elimination characteristics of thiopental may be more important determinants of intersubject differences in fetal drug exposure than differences in dose or delta t.
Similar articles
- Pharmacokinetics and plasma binding of thiopental. I: Studies in surgical patients.Morgan DJ, Blackman GL, Paull JD, Wolf LJ.Morgan DJ, et al.Anesthesiology. 1981 Jun;54(6):468-73. doi: 10.1097/00000542-198106000-00005.Anesthesiology. 1981.PMID:7235274
- Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients.Russo H, Brès J, Duboin MP, Roquefeuil B.Russo H, et al.Eur J Clin Pharmacol. 1995;49(1-2):127-37. doi: 10.1007/BF00192371.Eur J Clin Pharmacol. 1995.PMID:8751034
- The pharmacokinetics of thiopental in pediatric surgical patients.Sorbo S, Hudson RJ, Loomis JC.Sorbo S, et al.Anesthesiology. 1984 Dec;61(6):666-70. doi: 10.1097/00000542-198412000-00007.Anesthesiology. 1984.PMID:6507924
- The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.Mitani GM, Steinberg I, Lien EJ, Harrison EC, Elkayam U.Mitani GM, et al.Clin Pharmacokinet. 1987 Apr;12(4):253-91. doi: 10.2165/00003088-198712040-00002.Clin Pharmacokinet. 1987.PMID:3297463Review.
- Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.Guay J, Grenier Y, Varin F.Guay J, et al.Clin Pharmacokinet. 1998 Jun;34(6):483. doi: 10.2165/00003088-199834060-00004.Clin Pharmacokinet. 1998.PMID:9646009Review.
Cited by
- Effects of propofol versus thiopental on Apgar scores in newborns and peri-operative outcomes of women undergoing emergency cesarean section: a randomized clinical trial.Tumukunde J, Lomangisi DD, Davidson O, Kintu A, Joseph E, Kwizera A.Tumukunde J, et al.BMC Anesthesiol. 2015 Apr 29;15:63. doi: 10.1186/s12871-015-0044-6.BMC Anesthesiol. 2015.PMID:25924776Free PMC article.Clinical Trial.
- Pharmacokinetic implications for the clinical use of propofol.Kanto J, Gepts E.Kanto J, et al.Clin Pharmacokinet. 1989 Nov;17(5):308-26. doi: 10.2165/00003088-198917050-00002.Clin Pharmacokinet. 1989.PMID:2684471Review.
- Elimination kinetics of thiopentone in mothers and their newborn infants.Gaspari F, Marraro G, Penna GF, Valsecchi R, Bonati M.Gaspari F, et al.Eur J Clin Pharmacol. 1985;28(3):321-5. doi: 10.1007/BF00543331.Eur J Clin Pharmacol. 1985.PMID:4007037
- Risk-benefit assessment of anaesthetic agents in the puerperium.Kanto J.Kanto J.Drug Saf. 1991 Jul-Aug;6(4):285-301. doi: 10.2165/00002018-199106040-00006.Drug Saf. 1991.PMID:1888444Review.
- Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.Eke AC, Gebreyohannes RD, Fernandes MFS, Pillai VC.Eke AC, et al.J Clin Pharmacol. 2023 Jun;63 Suppl 1(Suppl 1):S34-S50. doi: 10.1002/jcph.2227.J Clin Pharmacol. 2023.PMID:37317492Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous